Literature DB >> 29694844

In vivo methods for acute modulation of gene expression in the central nervous system.

Andrzej W Cwetsch1, Bruno Pinto2, Annalisa Savardi1, Laura Cancedda3.   

Abstract

Accurate and timely expression of specific genes guarantees the healthy development and function of the brain. Indeed, variations in the correct amount or timing of gene expression lead to improper development and/or pathological conditions. Almost forty years after the first successful gene transfection in in vitro cell cultures, it is currently possible to regulate gene expression in an area-specific manner at any step of central nervous system development and in adulthood in experimental animals in vivo, even overcoming the very poor accessibility of the brain. Here, we will review the diverse approaches for acute gene transfer in vivo, highlighting their advantages and disadvantages with respect to the efficiency and specificity of transfection as well as to brain accessibility. In particular, we will present well-established chemical, physical and virus-based approaches suitable for different animal models, pointing out their current and future possible applications in basic and translational research as well as in gene therapy.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Electroporation; In vivo genetic manipulations; Nanoparticles; Polymers; Sonoporation; Viruses

Mesh:

Year:  2018        PMID: 29694844      PMCID: PMC6080705          DOI: 10.1016/j.pneurobio.2018.04.008

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  269 in total

1.  Ephrin-as guide the formation of functional maps in the visual cortex.

Authors:  Jianhua Cang; Megumi Kaneko; Jena Yamada; Georgia Woods; Michael P Stryker; David A Feldheim
Journal:  Neuron       Date:  2005-11-23       Impact factor: 17.173

2.  Manipulating Potassium Channel Expression and Function in Hippocampal Neurons by In Utero Electroporation.

Authors:  Kang Wang
Journal:  Methods Mol Biol       Date:  2018

3.  Deoxycholic Acid-Conjugated Polyethylenimine for Delivery of Heme Oxygenase-1 Gene in Rat Ischemic Stroke Model.

Authors:  Jungju Oh; Min Sang Lee; Ji Hoon Jeong; Minhyung Lee
Journal:  J Pharm Sci       Date:  2017-08-02       Impact factor: 3.534

4.  Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells.

Authors:  T Ono; Y Fujino; T Tsuchiya; M Tsuda
Journal:  Neurosci Lett       Date:  1990-09-18       Impact factor: 3.046

5.  A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro.

Authors:  C Kneuer; M Sameti; U Bakowsky; T Schiestel; H Schirra; H Schmidt; C M Lehr
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

6.  RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.

Authors:  Yikun Gao; Zhan-You Wang; Jinghai Zhang; Youxi Zhang; Hong Huo; Tianyi Wang; Tongying Jiang; Siling Wang
Journal:  Biomacromolecules       Date:  2014-02-27       Impact factor: 6.988

7.  Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size.

Authors:  Issei Takeuchi; Haruhiko Onaka; Kimiko Makino
Journal:  Biomed Mater Eng       Date:  2018       Impact factor: 1.300

8.  Ultrasound-based nonviral gene delivery induces bone formation in vivo.

Authors:  D Sheyn; N Kimelman-Bleich; G Pelled; Y Zilberman; D Gazit; Z Gazit
Journal:  Gene Ther       Date:  2007-11-22       Impact factor: 5.250

9.  Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.

Authors:  Hayate Javed; Sindhu A Menon; Karima M Al-Mansoori; Abdelmojib Al-Wandi; Nour K Majbour; Mustafa T Ardah; Shiji Varghese; Nishant N Vaikath; M Emdadul Haque; Mimoun Azzouz; Omar Ma El-Agnaf
Journal:  Mol Ther       Date:  2015-12-24       Impact factor: 11.454

10.  Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

Authors:  Xin Yu; Xiquan Liang; Huimin Xie; Shantanu Kumar; Namritha Ravinder; Jason Potter; Xavier de Mollerat du Jeu; Jonathan D Chesnut
Journal:  Biotechnol Lett       Date:  2016-02-18       Impact factor: 2.461

View more
  6 in total

1.  Biolistic transfection and expression analysis of acute cortical slices.

Authors:  Mohammad I K Hamad; Solieman Daoud; Petya Petrova; Obada Rabaya; Abdalrahim Jbara; Nesrine Melliti; Sarah Stichmann; Gebhard Reiss; Joachim Herz; Eckart Förster
Journal:  J Neurosci Methods       Date:  2020-02-28       Impact factor: 2.390

Review 2.  Battling Neurodegenerative Diseases with Adeno-Associated Virus-Based Approaches.

Authors:  Olja Mijanović; Ana Branković; Anton Borovjagin; Denis V Butnaru; Evgeny A Bezrukov; Roman B Sukhanov; Anastasia Shpichka; Peter Timashev; Ilya Ulasov
Journal:  Viruses       Date:  2020-04-18       Impact factor: 5.048

Review 3.  Cell and Gene Therapies for Mucopolysaccharidoses: Base Editing and Therapeutic Delivery to the CNS.

Authors:  Chloe L Christensen; Rhea E Ashmead; Francis Y M Choy
Journal:  Diseases       Date:  2019-06-26

4.  A rat model of a focal mosaic expression of PCDH19 replicates human brain developmental abnormalities and behaviours.

Authors:  Andrzej W Cwetsch; Ilias Ziogas; Roberto Narducci; Annalisa Savardi; Maria Bolla; Bruno Pinto; Laura E Perlini; Silvia Bassani; Maria Passafaro; Laura Cancedda
Journal:  Brain Commun       Date:  2022-04-05

Review 5.  Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia.

Authors:  Rajalakshmi Rajendran; Krishnakumar Neelakandha Menon; Sreeja Chandrasekharan Nair
Journal:  Adv Pharm Bull       Date:  2021-10-02

6.  Identification and prevention of heterotopias in mouse neocortical neural cell migration incurred by surgical damages during utero electroporation procedures.

Authors:  Bolin Wang; Liting Ji; Kausik Bishayee; Changyu Li; Sung-Oh Huh
Journal:  Anim Cells Syst (Seoul)       Date:  2020-03-09       Impact factor: 1.815

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.